ES2136626T3 - Peptidos con modificaciones en el extremo de n con efecto antagonista de bradiquinina. - Google Patents

Peptidos con modificaciones en el extremo de n con efecto antagonista de bradiquinina.

Info

Publication number
ES2136626T3
ES2136626T3 ES93105336T ES93105336T ES2136626T3 ES 2136626 T3 ES2136626 T3 ES 2136626T3 ES 93105336 T ES93105336 T ES 93105336T ES 93105336 T ES93105336 T ES 93105336T ES 2136626 T3 ES2136626 T3 ES 2136626T3
Authority
ES
Spain
Prior art keywords
formula
direct link
rest
bradiquinine
peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93105336T
Other languages
English (en)
Spanish (es)
Inventor
Gerhard Dr Breipohl
Stephan Dr Henke
Jochen Dr Knolle
Bernward Prof Dr Scholkens
Hans-Georg Dr Alpermann
Hermann Dr Gerhards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Application granted granted Critical
Publication of ES2136626T3 publication Critical patent/ES2136626T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/18Kallidins; Bradykinins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Transceivers (AREA)
  • Mobile Radio Communication Systems (AREA)
ES93105336T 1992-04-04 1993-03-31 Peptidos con modificaciones en el extremo de n con efecto antagonista de bradiquinina. Expired - Lifetime ES2136626T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4211406 1992-04-04

Publications (1)

Publication Number Publication Date
ES2136626T3 true ES2136626T3 (es) 1999-12-01

Family

ID=6456125

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93105336T Expired - Lifetime ES2136626T3 (es) 1992-04-04 1993-03-31 Peptidos con modificaciones en el extremo de n con efecto antagonista de bradiquinina.

Country Status (25)

Country Link
US (1) US5597803A (en, 2012)
EP (1) EP0564972B1 (en, 2012)
JP (1) JP3426639B2 (en, 2012)
KR (1) KR100273825B1 (en, 2012)
CN (1) CN1040330C (en, 2012)
AT (1) ATE183197T1 (en, 2012)
AU (1) AU667707B2 (en, 2012)
BR (1) BR9301436A (en, 2012)
CA (1) CA2093305A1 (en, 2012)
CZ (1) CZ285698B6 (en, 2012)
DE (1) DE59309726D1 (en, 2012)
DK (1) DK0564972T3 (en, 2012)
ES (1) ES2136626T3 (en, 2012)
FI (1) FI931474A7 (en, 2012)
GR (1) GR3031543T3 (en, 2012)
HU (1) HU217613B (en, 2012)
IL (1) IL105287A (en, 2012)
MX (1) MX9301926A (en, 2012)
NO (1) NO311941B1 (en, 2012)
NZ (1) NZ247317A (en, 2012)
PL (1) PL175901B1 (en, 2012)
RU (1) RU2109747C1 (en, 2012)
SK (1) SK281970B6 (en, 2012)
TW (1) TW258739B (en, 2012)
ZA (1) ZA932399B (en, 2012)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100360639B1 (ko) * 1994-03-09 2003-01-30 코르텍, 인크. N-치환글리신함유브라디키닌길항제펩티드
FR2739553B1 (fr) * 1995-10-06 1998-01-02 Oreal Utilisation d'antagonistes de la bradykinine pour stimuler ou induire la pousse des cheveux et/ou stopper leur chute
DE19612067A1 (de) * 1996-03-27 1997-10-02 Hoechst Ag Verwendung von Bradykinin-Antagonisten zur Herstellung von Arzneimitteln zur Behandlung von chronisch fibrogenetischen Lebererkrankungen und akuten Lebererkrankungen
FR2790260B1 (fr) 1999-02-26 2001-05-04 Fournier Ind & Sante Nouveaux composes de n-(benzenesulfonamide), procede de preparation et utilisation en therapeutique
RU2251433C2 (ru) * 1999-04-29 2005-05-10 Ново Нордиск А/С Применение гепаринсвязывающих антагонистов в ингибировании высвобождения брадикинина
US6699486B1 (en) 1999-11-18 2004-03-02 Bolla Corporation Treatment or prevention of photoaging and skin cancer
US7105172B1 (en) 1999-11-18 2006-09-12 Bolla John D Treatment of rosacea
US20040248809A1 (en) * 2003-02-07 2004-12-09 Aventis Pharma Deutschland Gmbh Use of antagonists of the bradykinin B2 receptor for the treatment of osteoarthrosis
SI21506A (sl) * 2003-05-08 2004-12-31 LEK farmacevtska dru�ba d.d. Postopek za pripravo perindoprila
WO2019202057A1 (en) 2018-04-20 2019-10-24 Fresenius Kabi Ipsum S.R.L. A method for production of high purity icatibant

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4210584A (en) * 1979-01-15 1980-07-01 Eli Lilly And Company Vindesine synthesis
US4350704A (en) * 1980-10-06 1982-09-21 Warner-Lambert Company Substituted acyl derivatives of octahydro-1H-indole-2-carboxylic acids
US4344949A (en) * 1980-10-03 1982-08-17 Warner-Lambert Company Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids
US4374847A (en) * 1980-10-27 1983-02-22 Ciba-Geigy Corporation 1-Carboxyalkanoylindoline-2-carboxylic acids
US4693993A (en) * 1985-06-13 1987-09-15 Stewart John M Bradykinin antagonist peptides
US4923963A (en) * 1987-09-02 1990-05-08 Nova Technology Limited Partnership Bradykinin antagonist peptides
EP0334244A3 (en) * 1988-03-25 1991-05-29 The Procter & Gamble Company Bradykinin antagonist peptides
IE63490B1 (en) * 1988-11-24 1995-05-03 Hoechst Ag Peptides having bradykinin antagonist action
DE4013270A1 (de) * 1990-04-26 1991-10-31 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE3926822A1 (de) * 1989-08-14 1991-02-21 Hoechst Ag Peptide mit bradykinin-antagonistischer wirkung
DE69012142D1 (de) * 1989-12-08 1994-10-06 Univ Boston Acylierte bradykininantagonisten und deren verwendung.
MX9100717A (es) * 1990-08-24 1992-04-01 Syntex Inc Antagonistas de la bradiquinina

Also Published As

Publication number Publication date
PL298362A1 (en) 1993-10-18
FI931474A0 (fi) 1993-04-01
AU3565193A (en) 1993-10-07
EP0564972A2 (de) 1993-10-13
IL105287A0 (en) 1993-08-18
CZ285698B6 (cs) 1999-10-13
BR9301436A (pt) 1993-10-13
SK28993A3 (en) 1993-11-10
NZ247317A (en) 1995-03-28
NO931287D0 (no) 1993-04-02
GR3031543T3 (en) 2000-01-31
CN1040330C (zh) 1998-10-21
ZA932399B (en) 1993-10-19
CN1077202A (zh) 1993-10-13
KR930021656A (ko) 1993-11-22
JP3426639B2 (ja) 2003-07-14
DK0564972T3 (da) 2000-01-24
EP0564972A3 (en) 1994-10-05
HU217613B (hu) 2000-03-28
SK281970B6 (sk) 2001-09-11
HU9300972D0 (en) 1993-06-28
DE59309726D1 (de) 1999-09-16
HUT64775A (en) 1994-02-28
NO311941B1 (no) 2002-02-18
KR100273825B1 (ko) 2000-12-15
EP0564972B1 (de) 1999-08-11
AU667707B2 (en) 1996-04-04
CZ57293A3 (en) 1994-03-16
US5597803A (en) 1997-01-28
CA2093305A1 (en) 1993-10-05
FI931474A7 (fi) 1993-10-05
PL175901B1 (pl) 1999-03-31
JPH0665289A (ja) 1994-03-08
IL105287A (en) 1999-12-31
NO931287L (no) 1993-10-05
MX9301926A (es) 1993-10-01
RU2109747C1 (ru) 1998-04-27
TW258739B (en, 2012) 1995-10-01
ATE183197T1 (de) 1999-08-15

Similar Documents

Publication Publication Date Title
ES2100187T3 (es) Derivados de carboestirilos y composiciones farmaceuticas que los contienen.
ATE188472T1 (de) 4-arylmethyloxymethyl piperidine als tachykinin antagonisten
MX9305379A (es) Nuevos derivados de aminoacidos, procedimiento para su preparacion y preparado farmaceutico que los contiene.
AR016762A1 (es) Compuestos del acido 4-bromo o 4-yodo fenilamino benzohidroxamico, formulaciones farmaceuticas y uso del mismo
ES2135416T3 (es) Compuestos de piridopiridazinonas y piridazintionas con actividad inhibidora de la pde iv.
AR247721A1 (es) Un procedimiento para la preparacion de compuestos de fenetanolamina y sus sales y solvatos farmaceuticamente aceptables
ES2076253T3 (es) N-(ariloxialquil)-heteroarilpiperidinas y -heteroarilpiperazinas, un procedimiento para su preparacion y su uso como medicamentos.
ES2161373T3 (es) Derivados de meta-guanidina, urea, tiourea o acido azaciclico-aminobenzoico como antagonistas de integrinas.
ES2189322T3 (es) Intermediarios utiles en la preparacion de inhibidores de encimas.
ES2053509T3 (es) Compuestos de acido 3-pirrolidiniltio-1-azabiciclo(3.2.0)hept-2-eno-2-carboxilico y procedimientos para su preparacion.
ES2136626T3 (es) Peptidos con modificaciones en el extremo de n con efecto antagonista de bradiquinina.
AR241018A2 (es) "n-(ciclopropil-triazinil-y-pirimidinil)-n'- (bencensulfonil) ureas con accion herbicida, procedimiento para su preparacion, intermediarios y composiciones que las contienen"
LV5794A4 (lv) Nonapeptidi ar bombezina antagonistu ipasibam
BR9307580A (pt) Compostos processo para a preparação dos mesmos composições farmacêuticas uso de um composto e processo de tratamento de um mamífero que inclui o ser humano
ES2095942T3 (es) Derivados de bencenoacetamida inhibidores del vih.
ATE175661T1 (de) Benzamid-derivate als vasopressin-antagonisten
ES8707925A1 (es) Un procedimiento para la preparacion de derivados de aminofenol
EA200300044A1 (ru) Новые замещенные фталиды, способ их получения и содержащие их фармацевтические композиции
DK0888337T3 (da) Piperidon-tachykininantagonister
CO4480026A1 (es) Nuevos compuestos que inhiben la accion de la lipoxigenasa y composiciones farmaceuticas que los contienen . . .
ES2104688T3 (es) Un procedimiento para la preparacion de un compuesto de tio-3-cefem 3-sustituido.
ES8707549A1 (es) Un procedimiento para preparar compuestos peptidicos sustituidos
ES8507472A1 (es) Procedimiento de preparar compuestos tratamiento de la hipertension
YU48176B (sh) Novi tetrahidroimidazo [1,4] benzodiazepin-2-(ti)oni i postupak njihovog dobijanja
GB1042296A (en) Novel dibenzoxazepinones, their preparation and compositions containing them

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 564972

Country of ref document: ES